换一批Quizartinib for Newly Diagnosed <i>FLT3</i>-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study.
第一作者：
Pau,Montesinos
第一单位：
Hospital Universitari I Politécnic La Fe, Valencia, Spain.
作者：
Pau,Montesinos [1]
;
Rebeca,Rodríguez-Veiga [1]
;
Juan Miguel,Bergua [2]
;
Jesús Lorenzo,Algarra Algarra [3]
;
Carmen,Botella [4]
;
Eduardo,Rodríguez-Arbolí [5]
;
Teresa,Bernal [6]
;
Mar,Tormo [7]
;
Maria,Calbacho [8]
;
Olga,Salamero [9]
;
Josefina,Serrano [10]
;
Victor,Noriega [11]
;
Juan Antonio,López-López [12]
;
Susana,Vives [13]
;
Jose Luis,López-Lorenzo [14]
;
Mercedes,Colorado [15]
;
Maria-Belén,Vidriales [16]
;
Raimundo,García Boyero [17]
;
Maria Teresa,Olave [18]
;
Pilar,Herrera Puente [19]
;
Olga,Arce [20]
;
Manuel,Barrios [21]
;
Maria,Jose Sayas [22]
;
Marta,Polo [23]
;
Maria Isabel,Gómez-Roncero [24]
;
Eva,Barragán [1]
;
Rosa,Ayala [8]
;
Carmen,Chillón [16]
;
Maria José,Calasanz [25]
;
Bruno,Paiva [25]
;
Blanca,Boluda [1]
;
Ignacio,Casas-Avilés [2]
;
Pilar,Lloret-Madrid [1]
;
Maria-José,Sánchez [26]
;
Carlos,Rodríguez-Medina [27]
;
Laida,Cuevas [28]
;
José Ángel,Raposo-Puglia [29]
;
M Carmen,Mateos [30]
;
Matxalen,Olivares [31]
;
Carmen,Martínez-Chamorro [32]
;
Natalia,Alonso [33]
;
Sandra,Suárez [34]
;
Irene,Sánchez-Vadillo [35]
;
María,Solé Rodríguez [36]
;
Bernardo Javier,González [37]
;
Antonio,Martínez-Francés [38]
;
Rebeca,Cuello [39]
;
Alfonso,Fernández [40]
;
David,Martínez-Cuadrón [1]
;
Jorge,Labrador [41]
;
PETHEMA group ;
PETHEMA Group
作者单位：
Hospital Universitari I Politécnic La Fe, Valencia, Spain.
[1]
Hospital San Pedro de Alcántara, Cáceres, Spain.
[2]
Hospital General de Albacete, Albacete, Spain.
[3]
Hospital General Universitario de Alicante, Alicante, Spain.
[4]
Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC, Universidad de Sevilla, Sevilla, Spain.
[5]
Instituto de Investigación Sanitaria del Principado de Asturias and Instituto Universitario de Oncología del Principado de Asturias, Hospital Universitario Central de Asturias, Oviedo, Spain.
[6]
Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, Valencia, Spain.
[7]
Hospital Universitario 12 de Octubre, Madrid, Spain.
[8]
University Hospital Vall d'Hebron, and Experimental Hematology, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
[9]
Hospital Universitario Reina Sofia, IMIBIC, UCO, Córdoba, Spain.
[10]
Hospital Universitario de A Coruña, A Coruña, Spain.
[11]
Hospital Universitario de Jaén, Jaén, Spain.
[12]
ICO-Hospital Germans Trias i Pujol-ICO, Institut de Recerca Josep Carreras, Badalona, Spain.
[13]
Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
[14]
Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
[15]
Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
[16]
Hospital General Universitario de Castellón, Castellón de la Plana, Spain.
[17]
Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
[18]
Hospital Universitario Ramón y Cajal, Madrid, Spain.
[19]
Hospital Universitario Basurto, Bilbao, Spain.
[20]
Hospital Universitario Regional de Málaga, Málaga, Spain.
[21]
Hospital Universitario Doctor Peset, Valencia, Spain.
[22]
Hospital Clínico San Carlos, Madrid, Spain.
[23]
Hospital General Universitario de Toledo, Toledo, Spain.
[24]
Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada, Universidad de Navarra (CIMA), IDISNA, CIBER-ONC CB16/12/00369, Pamplona, Spain.
[25]
Hospital Universitario Lucus Augusti, Lugo, Spain.
[26]
Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain.
[27]
Hospital Universitario Araba-Txagorritxu, Araba, Spain.
[28]
Hospital Universitario Puerta del Mar, Cádiz, Spain.
[29]
Hospital Universitario de Navarra, Navarra, Spain.
[30]
Hospital Galdakao-Usansolo Ospitalea, Bizkaia, Spain.
[31]
Hospital Universitario Quirónsalud Madrid and European University of Madrid, Madrid, Spain.
[32]
University Hospital of Santiago de Compostela, IDIS, Santiago de Compostela, Spain.
[33]
Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
[34]
Hospital Universitario La Paz, Madrid, Spain.
[35]
Hospital Universitario Juan Ramón Jiménez, Huelva, Spain.
[36]
Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
[37]
Hospital General Universitario Santa Lucía, Murcia, Spain.
[38]
Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
[39]
Hospital Universitario Virgen de la Victoria, Málaga, Spain.
[40]
Hospital Universitario de Burgos, Burgos, Spain.
[41]
医学主题词
人类(Humans);fms样酪氨酸激酶3(fms-Like Tyrosine Kinase 3);双盲法(Double-Blind Method);中年人(Middle Aged);女(雌)性(Female);男(雄)性(Male);成年人(Adult);苯脲化合物(Phenylurea Compounds);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);苯并噻唑类(Benzothiazoles);老年人(Aged);青年人(Young Adult);青少年(Adolescent);串联重复序列(Tandem Repeat Sequences);蛋白激酶抑制剂(Protein Kinase Inhibitors)
DOI
10.1200/JCO-25-01841
PMID
41082703
发布时间
2026-05-28
- 浏览1
Journal of clinical oncology
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
